A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients

NCT00813865 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Gaucher Disease
Type 1 Gaucher Disease
Gaucher Disease, Type 1

Interventions

DRUG: afegostat tartrate

Sponsor

Amicus Therapeutics